Suitable for high-density cultures of MDCK cells, under serum-free and protein-free conditions. Supports rapid cell proliferation. Also suitable for MDCK adherent cells’ rapid suspension adaptation, supporting their efficient production of the influenza virus. Xeno series media has been applied in the first serum-free suspension cell-based production of the human influenza vaccine, which has obtained IND approval and is currently in clinical trials stage.